IACQ · Irenic Acquisition Corp.

Irenic Acquisition Corp. is a classic blank-check SPAC incorporated in March 2026 and structured under Cayman Islands law to raise capital for a future acquisition. Its entire business model rests on identifying, negotiating, and completing a business combination with one or more operating companies within 24 months of its IPO closing — a hard deadline that triggers mandatory liquidation and return of trust funds to public shareholders if unmet. The offering comprises 22 million Units at $10.00 each, totaling $220 million in gross proceeds, with an additional 3.3 million Units available via the underwriters’ over-allotment option. Critically, all proceeds — plus interest earned — are deposited into a segregated U.S. trust account, inaccessible for general corporate purposes. This structure insulates public investors but also means the company has zero operating revenue, no assets beyond cash in trust, and no earnings history: it is purely a financial vehicle. The Sponsor holds 6.325 million Founder Shares, representing 20% of the post-IPO equity, but those shares are subject to forfeiture depending on how much of the over-allotment option is exercised — a mechanism designed to preserve the 20% ownership stake. Governance is tightly controlled: founders retain exclusive voting rights on director elections until a business combination closes, and any deal with an affiliate requires an independent fairness opinion. Key risks are structural and binary: failure to find a suitable target within the deadline results in full liquidation, while success hinges entirely on the quality of the acquired business and integration execution — neither of which is disclosed or assessable at this stage. The Sponsor and officers have contractually waived all claims to trust funds, meaning their indemnification rights depend entirely on the company’s ability to generate external cash flow post-combination or maintain sufficient non-trust assets — a material limitation given the SPAC’s pre-combination balance sheet consists almost entirely of the trust. From an investor perspective, this filing represents pure optionality on a future acquisition, with value creation entirely contingent on the sponsor’s ability to source, price, and execute a transaction that delivers superior returns relative to the risk-adjusted cost of holding cash in trust. There is no current financial performance to evaluate, no product-market fit to assess, and no customer traction to validate — only the credibility, track record, and alignment of the sponsor team, none of which is detailed in the filing beyond names and titles.